Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

GSK receives European approval for Duodart prostate drug, expects national licenses this year
Yahoo/AP
Wednesday, March 31, 2010 - 8:54am
tags:
GSK, Europe, Duodart, enlarged prostate
Isis, GlaxoSmithKline in Drug Collaboration
TheStreet.com
Wednesday, March 31, 2010 - 8:14am
tags:
partnerships, Isis Pharmaceuticals, GSK
Small-Cap China Pharma Stock Could Double
TheStreet.com
Wednesday, March 31, 2010 - 8:13am
tags:
China, Pfizer, China Pharma Holdings
Should Crestor Be Prescribed As A Preventive Med?
Pharmalot
Wednesday, March 31, 2010 - 8:11am
tags:
AstraZeneca, Crestor
Sanofi, BMS prevail in Plavix-generic fight
Fierce Pharma
Wednesday, March 31, 2010 - 8:10am
tags:
Plavix, generics, Bristol-Myers Squibb, Sanofi
Eisai Seeks Approval for Breast Cancer Drug Globally
Bloomberg
Wednesday, March 31, 2010 - 8:09am
tags:
Eisai, breast cancer, Eribulin
Hearing Loss Could Be A Win For GenVec
Forbes
Wednesday, March 31, 2010 - 8:07am
tags:
GenVec, Novartis, TNFerade
The FTC Is Losing Its War on Expensive Drugs -- But Doesn't Know It Yet
BNET Pharma
Tuesday, March 30, 2010 - 6:21pm
tags:
FTC, pay-for-delay, generics
Does Daiichi want full control of Ranbaxy?
Fierce Pharma
Tuesday, March 30, 2010 - 6:18pm
tags:
Ranbaxy, Daiichi Sankyo, India
What a Certriad Delay Means for Abbott
Minyanville
Tuesday, March 30, 2010 - 6:17pm
tags:
Abbott Laboratories, Certriad, AstraZeneca
Lilly’s Move To Fix Europe
WSJ Online
Tuesday, March 30, 2010 - 6:16pm
tags:
Eli Lilly, John Lechleiter, Europe
Doctors Get Reprieve From 21% Medicare Payment Cut
Bloomberg
Tuesday, March 30, 2010 - 11:23am
tags:
physicians, Medicare
Genzyme's Mipomersen: Liver Side Effects Could Limit a Promising Cholesterol Drug
BNET Pharma
Tuesday, March 30, 2010 - 11:15am
tags:
mipomersen, Genzyme
Myriad falls on patent ruling; drug indices slip
Marketwatch
Tuesday, March 30, 2010 - 11:14am
tags:
Myriad, patents, drug stocks
Ethicon Endo-Surgery Announces Receipt of Offer to Purchase Breast Care Business
Yahoo
Tuesday, March 30, 2010 - 10:55am
tags:
M&A, Ethicon-Endo Surgery, Devicor
Demand for BioCryst Flu Drug Still Low
TheStreet.com
Tuesday, March 30, 2010 - 10:30am
tags:
Biocryst, peramivir
Patent Office to Medicines Co.: "Too Bad You Can't Count. Oops -- We Can't Either"
BNET Pharma
Tuesday, March 30, 2010 - 10:27am
tags:
patents, Medicines Company, Angiomax
Feds Want Documents on Boston Scientific’s Defibrillator Recall
WSJ Online
Tuesday, March 30, 2010 - 10:04am
tags:
Boston Scientific, defibrillators, recalls
On second thought, NICE backs Sanofi's Multaq
Fierce Pharma
Tuesday, March 30, 2010 - 10:02am
tags:
NICE, Sanofi, Multaq
7 Firms Developing RNAi Drugs
TheStreet.com
Tuesday, March 30, 2010 - 9:53am
tags:
RNAi, Isis Pharmaceuticals, Merck, MRNA, Alnylam, RXi Pharmaceuticals, Sangamo BioSciences, Tekmira Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.